Navigation Links
Cambridge Semantics to Highlight Innovations in Drug Safety and Business Development at DIA 2013
Date:6/13/2013

Boston, Ma (PRWEB) June 13, 2013

Cambridge Semantics will be a featured presenter at DIA 2013 taking place June 23rd through the 27th in Boston. As part of the Innovation Theater track, Cambridge Semantics will showcase how technology innovations made possible by semantics can help pharmaceutical companies improve drug safety and bolster business development while minimizing risk.

The most important data-related challenge facing pharma today is the ability to use data to make critical business decisions. Most of these decisions don’t need Big Data: they simply need the right data at the right time. Semantic Web standards enable pharmaceutical organizations to make data smarter by offering greater data access and data understanding, allowing them to more effectively mitigate risk across the drug development and commercialization spectrum.

Session information
Tuesday, June 25th at Noon EDT
Title: “How Can Technology Change the Way Pharmas Handle Risk? Innovations in Drug Safety and Business Development
Location: Exhibit Hall

Based on Semantic Web technologies, the award-winning Anzo Pharma Competitive Intelligence Solution from Cambridge Semantics is currently in use at some of the world’s top biopharma organizations. R&D teams, business development, marketing and knowledge management groups leverage Anzo to easily route targeted information to the right people at the right time from the right sources, incorporating both structured and unstructured data. As a result, pharmaceutical organizations can harmonize information more rapidly and make better business decisions.

To learn more about Cambridge Semantics and the award winning Anzo Pharma Competitive Intelligence Solution please visit http://www.cambridgesemantics.com.

About Cambridge Semantics
Cambridge Semantics provides the award-winning Anzo software suite, an open platform for building interactive Unified Information Access (UIA) solutions. Enterprises face an increasing need to rapidly discover, understand, combine, and act on data from diverse sources both from within and across organizational boundaries. Anzo makes it easy for both IT and end users to deal with this need by rapidly creating solutions that leverage unified access to structured and unstructured data from varied sources in the context of specific business problems.

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10826188.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
2. Stevenage Bioscience Catalyst to Welcome Cambridge University Researchers
3. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
4. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
5. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
6. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
7. Cambridge Semantics to Speak at 2013 Bio-IT World Conference & Expo
8. Cambridge College School of Management Program Hosts a Panel Discussion On Trends and Opportunities In Health Information Technology
9. Cambridge Semantics to Present the Case for Unified Information Access at Enterprise Data World 2013
10. Industry Leader Linguamatics Hosts Record-breaking Spring Users Conference in Cambridge, UK
11. Cambridge Semantics Wins SIIA Software CODiE Award for Best Business Intelligence and Analytics Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... ... Food and Drug Administration (FDA) inspection at our Dilworth, MN site. The inspection ... issued. This inspection was conducted as part of a routine Bioresearch Monitoring Program ...
(Date:8/15/2017)... After spending the past two years building a state-of-the-art technology which ... offers this platform to healthcare stakeholders (hospitals, foundations, biopharma companies etc.) ... collection vis a vis their members, under their own brand. Three ... offer. ... ...
(Date:8/15/2017)... ... August 15, 2017 , ... Pittcon is ... for analytical and scientific instruments. This year’s symposium, organized by the Pittcon 2018 ... Spectrometry for Bioanalytical Applications.” This dynamic presentation will discuss novel ionization processes, high ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum ... 360° (IO360°) programming through a series of upcoming panels and events. The partnership culminates ... at The Roosevelt Hotel in New York City. , “With our experience in producing ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
Breaking Biology News(10 mins):